Company Overview of Xstelos Holdings, Inc.
Xstelos Holdings, Inc. operates a specialty pharmaceutical company in the United States. Its principal product includes Testim, a gel for testosterone replacement therapy. The company has licensed its Testim product to Auxilium Pharmaceuticals, Inc, which markets it in the United States, Europe, and Canada. Xstelos Holdings, Inc. owns and leases a 16,434 square foot commercial building situated on approximately 14 acres of land in Exeter, New Hampshire. The company is based in New York, New York.
630 Fifth Avenue
New York, NY 10020
Founded in 2004
Key Executives for Xstelos Holdings, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Xstelos Holdings, Inc., please visit www.footstar.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.